We speculate that hyper-methylation of the promoter region might abrogate lnc-RAB11B-AS1 expression, and inhibition of methylation in lnc-RAB11B-AS1 might be beneficial for treatment of osteosarcoma. The gene discussed is RAB11B; the disease is osteosarcoma.